SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending as investors anticipate upcoming earnings, with the community actively discussing potential surprises and raised guidance. Bullish sentiment is high, and many are holding positions, while some anticipate a post-earnings sell-off, a pattern observed in previous quarters. Discussions also include long-term growth potential, S&P 500 inclusion, and the impact of potential interest rate cuts.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph ($HBAR) is trending amid anticipation of a spot ETF approval and discussions around its potential impact. The community is actively discussing potential price targets and the broader implications of institutional investment. Some investors view it as a promising alternative within the crypto space, while others urge caution until clearer regulations are in place.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics ($NTLA) is trending due to a temporary halt in patient dosing for two late-stage trials after a participant experienced liver injury, causing a significant stock decline. The community is actively discussing the implications of this setback, including potential delays and the possibility of positive catalysts, while Ark Invest's recent purchase adds a layer of intrigue. Some traders believe the selloff is an overreaction and are anticipating a price bounce.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets and Data Centers. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

GLXY is trending downwards after announcing a private offering of exchangeable senior notes, leading to community debate on whether this is a strategic move for growth or a dilution trap. While some investors see it as a means to finance data center expansion and AI initiatives, others express concerns about the timing and potential impact on the stock price. The community is closely watching for further news and developments to gauge the long-term implications.

ETHZilla Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palm Beach, FL.

ETHZilla Corp

ETHZilla Corporation

ETHZ is trending as investors discuss the company's stock buyback program and its relationship to Ethereum's potential growth, with some seeing it as undervalued relative to its ETH holdings. Community members are weighing the impact of outstanding warrants and potential dilution against the buyback, while others point to the company's exposure to the crypto market as a potential catalyst. Chatter suggests the stock may have meme potential.

Bed Bath & Beyond, Inc. engages in the provision of an e-commerce platform. It offers furniture and home furnishing products and services. The company was founded on May 5, 1997 and is headquartered in Murray, UT.

Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc

Bed Bath & Beyond ($BBBY) is trending as the community discusses its potential, particularly its ties to blockchain through Tzero, while drawing comparisons to meme stock favorite, Gamestock ($GME).  Recent news includes a new ticker and speculation on strategic partnerships, while traders debate the company's direction and potential for a turnaround.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group (UNH) is trending as investors discuss its upcoming earnings report and potential market impact, especially given mixed sector signals from peers like ELV and MOH. Community members are weighing factors like premium adjustments, the Optum division's performance, and broader healthcare industry trends, with some anticipating a significant move post-earnings. Speculation includes possible government actions affecting healthcare and potential shifts in investor sentiment.

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. Tempest Therapeutics was founded in 2011 and is headquartered in Brisbane, CA.

Tempest Therapeutics Inc

TPST is trending amid community speculation about a potential buyout, with Roche being a frequently mentioned suitor due to existing collaborations. Discussions revolve around trial updates, potential deal structures, and the expiry of executive options, adding a sense of urgency. Some investors are analyzing MTS Partners' historical deals, while others point to technical indicators and volume patterns as potential signals for an imminent announcement.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet (GOOG) is trending as investors anticipate earnings and discuss the potential impact of AI advancements on its search and cloud businesses. Community members are highlighting Google's AI initiatives, including updates on its AI search features and Anthropic partnership, while some express concerns about competition. Additionally, a Barron's article noting Google's agreement to buy power from a closed nuclear plant is circulating, showcasing the company's investments in renewable energy.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Recent news and analyst upgrades have fueled bullish sentiment around GOOGL, particularly regarding its AI initiatives and cloud services. The community is actively discussing potential upside, with some anticipating new all-time highs and a price target of $300+ after upcoming earnings. However, some traders are cautious, noting technical resistance and expressing concerns about short-term pullbacks amid broader market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AtriCure to Participate in Upcoming Investor Conferences

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management...

AtriCure (ATRC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for AtriCure (ATRC) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

AtriCure (ATRC) Reports Q2 Loss, Tops Revenue Estimates

AtriCure (ATRC) delivered earnings and revenue surprises of +86.67% and +4.61%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Abbott (ABT) Q2 Earnings and Revenues Top Estimates

Abbott (ABT) delivered earnings and revenue surprises of +0.80% and +0.63%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Has Amneal Pharmaceuticals (AMRX) Outpaced Other Medical Stocks This Year?

Here is how Amneal Pharmaceuticals (AMRX) and AtriCure (ATRC) have performed compared to their sector so far this year.

Are Medical Stocks Lagging  Astellas Pharma (ALPMY) This Year?

Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year?

Does AtriCure (ATRC) Have the Potential to Rally 54.7% as Wall Street Analysts Expect?

Why Barclays sees a buying opportuntiy in MedTech stocks

Investing.com -- Barclays said in a note Monday that it sees attractive entry points in MedTech stocks, as recent weakness in some sector leaders has created a buying opportunity despite the group’s strong year-to-date performance.

AtriCure Reports Fourth Quarter 2024 and Full Year 2024 Financial Results

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management...

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.

Atricure Inc

Will Alphabet ($GOOGL) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

ATRC
Atricure Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ATRC News

ATRCAtricure Inc